DVA vs PODD — Key Metrics
| Metric | DVA (DAVITA INC) | PODD (INSULET CORP) |
|---|---|---|
| Price | 161.79 | 139.98 |
| Market Cap | 10.18 Billion | 9.71 Billion |
| P/E (TTM) | 11.72 | 22.8 |
| P/B (Quarterly) | -20.571 | 7.249 |
| P/S (TTM) | 0.72 | 3.04 |
| Net Profit Margin (TTM) | 6.5 | 13.4 |
| Gross Margin (TTM) | 32.3 | 71.9 |
| ROE (TTM) | -133.2 | 29.5 |
| Revenue Growth YoY (TTM) | n/a | n/a |
Upfront Investment - S&P 500 Stock Comparison & AI Analysis
AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.
Performance Comparison
AI Model Recommendation
Outperform
Outperform
Recommendation Summary
Both stocks are projected to outperform the market over the next year. If you have to make a choice, Upfront Recommendation: DVA.
Financial Metrics
| DVA | Metrics | PODD |
|---|---|---|
| $161.79 | Price | $139.98 |
| — | Market Capitalization | — |
| 11.72 | Price to Earnings Ratio | 22.8 |
| 0.72 | Price to Sales | 3.04 |
| 7.87 | Price to FCF Ratio | 41.75 |
| 2.23 | Price to Gross Profit | 4.24 |
| 2.5 | Price to Current Assets | 4.76 |
DVA vs PODD at a glance
Davita INC (DVA) and Insulet Corp (PODD) are both in the Healthcare sector. They are similar in size: $10.2 billion and $9.7 billion in market value.
On trailing-twelve-month figures, DVA trades at 11.7 times trailing earnings and PODD at 22.8; net profit margins are 6.5% and 13.4%.
The Upfront Investment model currently rates both Outperform as of November 18, 2026. The rating ranks the model's medium-term return forecast against the other stocks it scores; it is a statistical forecast, not investment advice.